Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacholiquine in Chronic Bronchitis
NCT02515799Phase 4Completed
- Sponsor
- bene-Arzneimittel GmbH
- Start
- Aug 2014
- Primary completion
- Jan 2015
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tyloxapol in chronic bronchitis (CB), chronic obstructive pulmonary disease (COPD), sponsored by bene-Arzneimittel GmbH. Started Aug 2014; status: completed.
02
Drugs
tyloxapol
03
Conditions
chronic bronchitis (CB)chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02515799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02515799.